Related Experiment Video
Updated: Mar 10, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Factor XIII Deficiency: A Silent Bleeder Behind a Normal Coagulation Profile
Ramesh Yadav1, Madhav Raj Karki2, Dikshya Pokhrel2
1Department of Paediatrics Birat Medical College Teaching Hospital Morang Nepal.
Abstract:
Factor XIII deficiency is a rare cause of bleeding disorder. An 8-month-old male infant presented with persistent bleeding from a minor lip cut injury, which was sustained 2 days prior. The bleeding did not stop despite local hemostatic measures. His medical history was notable for spontaneous intradermal bleeds at different times and umbilical stump bleeding during the neonatal period. On examination, there were multiple petechiae and a large ecchymosis over the chest. Routine hematological and coagulation parameters were within normal limits. von Willebrand factor, factor VIII, and factor IX levels were normal. However, a qualitative 5M urea clot solubility test followed by factor XIII assay yielded abnormal results, confirming factor XIII deficiency. The patient was managed with fresh frozen plasma (FFP) and supportive care. Four months later, the patient presented with lethargy and vomiting, later diagnosed as epidural hematoma. The patient received FFP, had a favorable stay in the pediatric intensive care unit, and was discharged with no neurological deficits and a prophylactic plan. This case underscores how factor XIII deficiency can elude detection in routine coagulation tests, emphasizing the importance of prompt diagnosis and timely administration of replacement therapy to prevent complications and associated constraints in a resource limited setting.
More Related Videos
Related Concept Videos
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

